Clearly, overweight and obese patients have increased cardiovascular (CV) risk factors, including hypertension, dyslipidemia, glucose abnormalities (impaired fasting glucose, metabolic syndrome, type II diabetes), and inflammation (1,2). Although a lack of physical activity is the primary cause of obesity (3-5), once obesity is manifest, physical activity and cardiorespiratory fitness progressively decline with weight gain. Therefore, it is not surprising that obesity is associated with a marked increased risk for most CV diseases.
Clearly, overweight and obese patients have increased cardiovascular (CV) risk factors, including hypertension, dyslipidemia, glucose abnormalities (impaired fasting glucose, metabolic syndrome, type II diabetes), and inflammation (1, 2) . Although a lack of physical activity is the primary cause of obesity (3) (4) (5) , once obesity is manifest, physical activity and cardiorespiratory fitness progressively decline with weight gain. Therefore, it is not surprising that obesity is associated with a marked increased risk for most CV diseases.
It is well known that obesity increases the risk for hypertension and coronary heart disease (CHD), which are leading causes of heart failure (HF) (2) . Not surprisingly, the prevalence of HF is markedly increased in the setting of obesity, with progressive increases in HF prevalence correlating with increasing severity of obesity (2, 6, 7) . Other related CV diseases (e.g., atrial fibrillation) are also more common in the setting of obesity (1, 2) .
Recently, it was demonstrated that "metabolically healthy obesity" did not increase the risk for CHD and first myocardial infarction, but even metabolically healthy obesity was associated with a significantly increased risk for HF (8, 9) . This is not surprising considering the effects of obesity on cardiac structure and function ( Figure 1 ) (2). Obesity has adverse effects on preload and afterload and on both the left and right chambers of the heart, markedly increasing overall CV risk, particularly for HF (2, 10) .
In this issue of JACC: Heart Failure, 2 papers utilizing state-of-the-art Doppler echocardiographic methodology demonstrate the adverse effects of obesity on cardiac structure and systolic and diastolic function, as well as on ventricular-arterial aging or stiffening (11, 12) . In the study by Kishi et al. State University System, Baton Rouge, Louisiana. The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
adverse effects of obesity on early cardiac and vascular structure and function, and provide ammunition for the potential of weight loss in preventing CV diseases, including HF.
Although purposeful weight loss appears especially promising for patients with more severe degrees of obesity, as we recently discussed elsewhere (2, (10) (11) (12) , despite the theoretical benefits of weight reduction (2, (10) (11) (12) (13) (14) , including the data reviewed in this issue (11, 12) , there is a paucity of data to support weight loss in overweight patients or those with mild degrees of obesity. As a result, the more recent HF management guidelines do not provide any firm recommendations for weight loss in HF, whereas increased physical activity and exercise training are recommended (15) . Conversely, there are considerable data to support the crucial role of cardiorespiratory fitness in improving prognosis, suggesting that cardiorespiratory fitness is a more important predictor of prognosis than is fatness for CV-related and all-cause mortality (11, 16, 17 These data demonstrate that cardiorespiratory fitness markedly alters the relationship between adiposity and prognosis in patients with CV diseases, including HF.
Thus, the lack of data on cardiorespiratory fitness was a significant limitation of both of these papers 
